Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Insulin Resistance, Diabetes clinical trials

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Insulin Resistance, Diabetes: 2 US clinical trials tracked, none currently recruiting.

Insulin Resistance, Diabetes is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Pennington Biomedical Research Center, running 1 of these trials.

Enrollment posture brief

Registry condition insulin-resistance-diabetes

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Insulin Resistance, Diab (th…0%
Open-enrollment share among volume-matched conditions near Insulin Resistance, Diabetes

Insulin Resistance, Diabetes has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Insulin Resistance, Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Insulin Resistance, Diabetes is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Insulin Resistance, Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

HOMA IR the standard testing for insulin resistance Diagnostic test
1 trials
Quantose IR and Quantose IGT analysis Diagnostic test
1 trials
exercise Behavioral
1 trials

US sites by state

Facility locations filed on Insulin Resistance, Diabetes trials. A trial with sites in several states counts in each.

Texas 1 trials
Louisiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Insulin Resistance, Diabetes page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Insulin Resistance, Diabetes trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pennington Biomedical Research Center sponsors the most Insulin Resistance, Diabetes trials on record, review their full trial history before evaluating a specific study. See Pennington Biomedical Research Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insulin Resistance, Diabetes condition card totals 2 registered trials; most-linked intervention HOMA IR the standard testing for insulin resistance; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.